GABAA-receptor mRNA expression in the prefrontal and temporal cortex of ALS patients

Journal of the Neurological Sciences

Volumn 250, Issue 1-2, 2006, Pages 124-132

  Petri, Susanne ^a   Kollewe, Katja ^a   Grothe, Claudia ^a   Hori, Akira ^a   Dengler, Reinhard ^a   Bufler, Johannes ^a   Krampfl, Klaus ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Amyotrophic laterals sclerosis; Extramotor brain regions; GABAA receptors; In situ hybridization histochemistry; Inhibitory neurotransmission

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; GLUTAMATE DECARBOXYLASE; MESSENGER RNA; RECEPTOR SUBUNIT;

4 AMINOBUTYRIC ACID METABOLISM; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPSY; BRAIN REGION; BRAIN SLICE; CEREBELLUM CORTEX; CONTROLLED STUDY; ENZYME REGULATION; GABAERGIC SYSTEM; GENE CONTROL; GENE EXPRESSION REGULATION; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; OCCIPITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; RNA ANALYSIS; STATISTICAL ANALYSIS; TEMPORAL CORTEX; TISSUE DISTRIBUTION; UPREGULATION;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; DOWN-REGULATION; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; HUMANS; MIDDLE AGED; MOTOR NEURONS; NERVE DEGENERATION; NEURAL INHIBITION; PREFRONTAL CORTEX; RECEPTORS, GABA-A; RNA, MESSENGER; TEMPORAL LOBE; UP-REGULATION;

EID: 33750509375     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.08.005     Document Type: Article

References (46)

1. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 6415 (1993) 59-62
2. Abrahams S., Goldstein L.H., Kew J.J., Brooks D.J., Lloyd C.M., Frith C.D., et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain 119 Pt 6 (1996) 2105-2120
3. Lloyd C.M., Richardson M.P., Brooks D.J., Al Chalabi A., and Leigh P.N. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain 123 Pt 11 (2000) 2289-2296
4. Abrahams S., Leigh P.N., Harvey A., Vythelingum G.N., Grise D., and Goldstein L.H. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia 38 6 (2000) 734-747
5. Abrahams S., Leigh P.N., and Goldstein L.H. Cognitive change in ALS: a prospective study. Neurology 64 7 (2005) 1222-1226
6. Gallassi R., Montagna P., Morreale A., Lorusso S., Tinuper P., Daidone R., et al. Neuropsychological, electroencephalogram and brain computed tomography findings in motor neuron disease. Eur Neurol 29 2 (1989) 115-120
7. Kew J.J., Leigh P.N., Playford E.D., Passingham R.E., Goldstein L.H., Frackowiak R.S., et al. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain 116 Pt 3 (1993) 655-680
8. Ludolph A.C., Langen K.J., Regard M., Herzog H., Kemper B., Kuwert T., et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 85 2 (1992) 81-89
9. Neary D., Snowden J.S., Mann D.M., Northen B., Goulding P.J., and Macdermott N. Frontal lobe dementia and motor neuron disease. J Neurol Neurosurg Psychiatry 53 1 (1990) 23-32
10. Neary D., Snowden J.S., and Mann D.M. Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS). J Neurol Sci 180 1-2 (2000) 15-20
11. Massman P.J., Sims J., Cooke N., Haverkamp L.J., Appel V., and Appel S.H. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 61 5 (1996) 450-455
12. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32 9 (2002) 797-803
13. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27 (2004) 723-749
14. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 344 22 (2001) 1688-1700
15. Kiaei M., Kipiani K., Petri S., Choi D.K., Chen J., Calingasan N.Y., et al. Integrative role of cPLA with COX-2 and the effect of non-steroidal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 93 2 (2005) 403-411
16. Sargsyan S.A., Monk P.N., and Shaw P.J. Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51 4 (2005) 241-253
17. Strong M.J., Kesavapany S., and Pant H.C. The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?. J Neuropathol Exp Neurol 64 8 (2005) 649-664
18. Hervias I., Beal M.F., and Manfredi G. Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve (2005)
19. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 8 (1988) 623-634
20. Heath P.R., and Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 26 4 (2002) 438-458
21. Tortarolo M., Grignaschi G., Calvaresi N., Zennaro E., Spaltro G., Colovic M., et al. Glutamate AMPA receptors change in motor neurons of SOD1(G93A) transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amyotrophic lateral sclerosis-like disease. J Neurosci Res 83 1 (2006) 134-146
22. Seeburg P.H., Wisden W., Verdoorn T.A., Pritchett D.B., Werner P., Herb A., et al. The GABAA receptor family: molecular and functional diversity. Cold Spring Harbor Symp Quant Biol 55 (1990) 29-40
23. Luddens H., Seeburg P.H., and Korpi E.R. Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors. Mol Pharmacol 45 5 (1994) 810-814
24. Mohler H., Knoflach F., Paysan J., Motejlek K., Benke D., Luscher B., et al. Heterogeneity of GABAA-receptors: cell-specific expression, pharmacology, and regulation. Neurochem Res 20 5 (1995) 631-636
25. Petri S., Krampfl K., Hashemi F., Grothe C., Hori A., Dengler R., et al. Distribution of GABAA receptor mRNA in the motor cortex of ALS patients. J Neuropathol Exp Neurol 62 10 (2003) 1041-1051
26. Kew J.J., Goldstein L.H., Leigh P.N., Abrahams S., Cosgrave N., Passingham R.E., et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. Brain 116 Pt 6 (1993) 1399-1423
27. Barnard E.A., Skolnick P., Olsen R.W., Mohler H., Sieghart W., Biggio G., et al. International Union of Pharmacology: XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50 2 (1998) 291-313
28. Brooks B.R., Miller R.G., Swash M., and Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1 5 (2000) 293-299
29. Akbarian S., Huntsman M.M., Kim J.J., Tafazzoli A., Potkin S.G., Bunney Jr. W.E., et al. GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex 5 6 (1995) 550-560
30. Jackson M., Lennox G., and Lowe J. Motor neurone disease-inclusion dementia. Neurodegeneration 5 4 (1996) 339-350
31. Abrahams S., Goldstein L.H., Simmons A., Brammer M., Williams S.C., Giampietro V., et al. Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain 127 Pt 7 (2004) 1507-1517
32. Kiernan J.A., and Hudson A.J. Frontal lobe atrophy in motor neuron diseases. Brain 117 Pt 4 (1994) 747-757
33. Abrahams S., Leigh P.N., Kew J.J., Goldstein L.H., Lloyd C.M., and Brooks D.J. A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. J Neurol Sci 129 Suppl (1995) 44-46
34. Vieregge P., Wauschkuhn B., Heberlein I., Hagenah J., and Verleger R. Selective attention is impaired in amyotrophic lateral sclerosis-a study of event-related EEG potentials. Brain Res Cogn Brain Res 8 1 (1999) 27-35
35. Waldemar G., Vorstrup S., Jensen T.S., Johnsen A., and Boysen G. Focal reductions of cerebral blood flow in amyotrophic lateral sclerosis: a [99mTc]-d,l-HMPAO SPECT study. J Neurol Sci 107 1 (1992) 19-28
36. Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C., Shaw C.E., Brooks D.J., et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15 3 (2004) 601-609
37. Turner M.R., Osei-Lah A.D., Hammers A., Al Chalabi A., Shaw C.E., Andersen P.M., et al. Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS. J Neurol Neurosurg Psychiatry 76 9 (2005) 1279-1285
38. Caramia M.D., Palmieri M.G., Desiato M.T., Iani C., Scalise A., Telera S., et al. Pharmacologic reversal of cortical hyperexcitability in patients with ALS. Neurology 54 1 (2000) 58-64
39. Baumann S.W., Baur R., and Sigel E. Subunit arrangement of gamma-aminobutyric acid type A receptors. J Biol Chem 276 39 (2001) 36275-36280
40. Klausberger T., Sarto I., Ehya N., Fuchs K., Furtmuller R., Mayer B., et al. Alternate use of distinct intersubunit contacts controls GABAA receptor assembly and stoichiometry. J Neurosci 21 23 (2001) 9124-9133
41. Sieghart W. Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol Rev 47 2 (1995) 181-234
42. Mohler H., Fritschy J.M., Luscher B., Rudolph U., Benson J., and Benke D. The GABAA receptors. From subunits to diverse functions. Ion Channels 4 (1996) 89-113
43. Whiting P.J., McKernan R.M., and Wafford K.A. Structure and pharmacology of vertebrate GABAA receptor subtypes. Int Rev Neurobiol 38 (1995) 95-138
44. Ince P., Stout N., Shaw P., Slade J., Hunziker W., Heizmann C.W., et al. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 19 4 (1993) 291-299
45. Gredal O., Pakkenberg H., Karlsborg M., and Pakkenberg B. Unchanged total number of neurons in motor cortex and neocortex in amyotrophic lateral sclerosis: a stereological study. J Neurosci Methods 95 2 (2000) 171-176
46. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney Jr. W.E., et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52 4 (1995) 258-266